STING1 and neoplasm: The same group also found that the adapter stimulator of interferon genes complex (STING) is directly activated by tumor-derived cytosolic DNA present within dendritic cells and triggers the activation of IFN-β production, thus enabling innate immune recognition of immunogenic tumors and subsequent effector T-cell infiltration [29].